Asia-Pacific Drug Discovery Market 2019-2028

MARKET OUTLOOK

As per a the publisher report, the drug discovery market in the Asia-Pacific region is expected to grow at a CAGR of 6.88% over the forecasted years 2019-2028 in terms of revenue.
China, Japan, India, South Korea, Australia & New Zealand, ASEAN countries, and Rest of APAC form the drug discovery market in the region.

Several CROs in South Korea are working actively on the ongoing programs for drug discovery. This includes the programs for curing various types of cancer, metabolic & neurological diseases, and bacterial infections. Also, the Korean Drug Development Fund (KDDF) and Celerion and have entered into a partnership to support the emerging drug discovery market of South Korea.

Australia has a well-established infrastructure in places like Victoria, Queensland, and New South Wales. Also, several other regions have been increasingly gaining access to high-end technology. New initiatives, such as the University of Queensland's Community for Open Antimicrobial Drug Discovery (CO-ADD), provide high-throughput antimicrobial screening free of cost for academic research groups. This is helping improve access to the technology. Victoria is a region renowned for generating and developing novel ideas, and is contributing various new drugs to the present pipeline. Further, multiple new stages are being added to the process of drug discovery. This is helping the drug discovery market to grow in Australia.

COMPETITIVE OUTLOOK

F Hoffmann-La Roche Ltd, Becton Dickinson & Company (BD), Abbott Laboratories Inc, Antares Pharma Inc, Merck & Co Inc, AstraZeneca Plc, Sanofi, and Pfizer Inc are some of the noted players in the drug discovery market.

1. Asia-Pacific Drug Discovery Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threats of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Covid-19 and Its Impact on Drug Discovery Market
2.4. PESTLE Outlook
2.5. Regulatory Framework
2.6. Value Chain Outlook
2.7. Market Attractiveness Index
2.8. Key Insight
2.9. Market Drivers
2.9.1. Growing Aged Population
2.9.2. Technological Advancements
2.9.3. Rise in Healthcare Expenditure
2.9.4. Surge in Lifestyle-Oriented Diseases
2.10. Market Restraints
2.10.1. Delay in Product Launches
2.10.2. Restricted Growth Rate Due to Generic Drugs
2.11. Market Opportunities
2.11.1. Significant Investment by Healthcare Industries in Improving Big Data Analytical Capabilities
2.11.2. Rising Demand for Specialty Medicines
2.12. Market Challenges
2.12.1. Poor Reimbursements Policies in Emerging Nations
2.12.2. Stringent Government Regulations

3. Drug Discovery Market Outlook - by Drug Type

3.1. Small Molecule Drug
3.2. Biologic Drug

4. Drug Discovery Market Outlook - by Technology

4.1. High Throughput Screening
4.2. Biochips
4.3. Bioinformatics
4.4. Pharmacogenomics and Pharmacogenetics
4.5. Combinatorial Chemistry
4.6. Nanotechnology
4.7. Spectroscopy
4.8. Metabolomics
4.9. Other Technologies

5. Drug Discovery Market Outlook - by Service

5.1. Drug Metabolism and Pharmacokinetics (Dmpk) Services
5.2. Chemical Services
5.3. Biological Services
5.4. Other Pharmaceutical Services

6. Drug Discovery Market Outlook - by End-User

6.1. Research Institutes
6.2. Pharmaceutical Companies
6.3. Contract Research Organizations (Cros)
6.4. Other End-Users

7. Drug Discovery Market – Asia-Pacific

7.1. Country Analysis
7.1.1. China
7.1.2. India
7.1.3. Japan
7.1.4. South Korea
7.1.5. Australia & New Zealand
7.1.6. Asean Countries
7.1.7. Rest of Asia-Pacific

8. Company Profiles

8.1. 3M Company
8.2. Abbott Laboratories Inc
8.3. Agilent Technologies Inc
8.4. Antares Pharma Inc
8.5. Astrazeneca plc
8.6. Bayer AG
8.7. Becton Dickinson & Company (Bd)
8.8. Boehringer Ingelheim
8.9. Eli Lily and Company
8.10. F Hoffmann-La Roche Ltd
8.11. GlaxoSmithKline LLC
8.12. Johnson & Johnson
8.13. Merck & Co Inc
8.14. Novartis
8.15. Pfizer Inc
8.16. Sanofi

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1 Asia-Pacific Drug Discovery Market, by Country, 2019-2028 ($ Million)
Table 2 Asia-Pacific Drug Discovery Market, by Technology, 2019-2028 ($ Million)
Table 3 Asia-Pacific Drug Discovery Market, by Drug Type, 2019-2028 ($ Million)
Table 4 Asia-Pacific Drug Discovery Market, by Service, 2019-2028 ($ Million)
Table 5 Asia-Pacific Drug Discovery Market, by End-User, 2019-2028 ($ Million)
Table 6 Asia-Pacific Drug Discovery Market, by Country, 2019-2028 ($ Million)

List of Figures

Figure 1 Asia-Pacific Drug Discovery Market, by Region, 2019-2028 ($ Million)
Figure 2 Asia-Pacific Drug Discovery Market, by Small Molecule Drug, 2019-2028 ($ Million)
Figure 3 Asia-Pacific Drug Discovery Market, by Biologic Drug, 2019-2028 ($ Million)
Figure 4 Asia-Pacific Drug Discovery Market, by High Throughput Screening, 2019-2028 ($ Million)
Figure 5 Asia-Pacific Drug Discovery Market, by Biochips, 2019-2028 ($ Million)
Figure 6 Asia-Pacific Drug Discovery Market, by Bioinformatics, 2019-2028 ($ Million)
Figure 7 Asia-Pacific Drug Discovery Market, by Pharmacogenomics and Pharmacogenetics, 2019-2028 ($ Million)
Figure 8 Asia-Pacific Drug Discovery Market, by Combinatorial Chemistry, 2019-2028 ($ Million)
Figure 9 Asia-Pacific Drug Discovery Market, by Nanotechnology, 2019-2028 ($ Million)
Figure 10 Asia-Pacific Drug Discovery Market, by Spectroscopy, 2019-2028 ($ Million)
Figure 11 Asia-Pacific Drug Discovery Market, by Metabolomics, 2019-2028 ($ Million)
Figure 12 Asia-Pacific Drug Discovery Market, by Other Technologies, 2019-2028 ($ Million)
Figure 13 Asia-Pacific Drug Discovery Market, by Drug Metabolism and Pharmacokinetics (Dmpk) Services, 2019-2028 ($ Million)
Figure 14 Asia-Pacific Drug Discovery Market, by Chemical Services, 2019-2028 ($ Million)
Figure 15 Asia-Pacific Drug Discovery Market, by Biological Services, 2019-2028 ($ Million)
Figure 16 Asia-Pacific Drug Discovery Market, by Other Pharmaceutical Services, 2019-2028 ($ Million)
Figure 17 Asia-Pacific Drug Discovery Market, by Research Institutes, 2019-2028 ($ Million)
Figure 18 Asia-Pacific Drug Discovery Market, by Pharmaceutical Companies, 2019-2028 ($ Million)
Figure 19 Asia-Pacific Drug Discovery Market, by Contract Research Organizations (Cros), 2019-2028 ($ Million)
Figure 20 Asia-Pacific Drug Discovery Market, by Other End-Users, 2019-2028 ($ Million)
Figure 21 China Drug Discovery Market 2019-2028 ($ Million)
Figure 22 India Drug Discovery Market 2019-2028 ($ Million)
Figure 23 Japan Drug Discovery Market 2019-2028 ($ Million)
Figure 24 South Korea Drug Discovery Market 2019-2028 ($ Million)
Figure 25 Australia & New Zealand Drug Discovery Market 2019-2028 ($ Million)
Figure 26 Asean Countries Drug Discovery Market 2019-2028 ($ Million)
Figure 27 Rest of Asia-Pacific Drug Discovery Market 2019-2028 ($ Million)